Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $36,237 - $53,650
23,531 New
23,531 $39,000
Q3 2023

Nov 15, 2023

SELL
$1.06 - $2.33 $1,573 - $3,457
-1,484 Reduced 3.05%
47,101 $51,000
Q2 2023

Aug 14, 2023

BUY
$2.15 - $3.49 $80,807 - $131,171
37,585 Added 341.68%
48,585 $111,000
Q1 2023

May 15, 2023

BUY
$1.99 - $2.68 $21,890 - $29,480
11,000 New
11,000 $27,000
Q2 2022

Aug 15, 2022

SELL
$1.31 - $2.69 $45,188 - $92,791
-34,495 Reduced 24.71%
105,106 $195,000
Q1 2022

May 16, 2022

SELL
$1.95 - $3.89 $22,126 - $44,139
-11,347 Reduced 7.52%
139,601 $292,000
Q4 2021

Feb 14, 2022

BUY
$3.81 - $6.16 $161,570 - $261,227
42,407 Added 39.07%
150,948 $595,000
Q3 2021

Nov 15, 2021

BUY
$3.38 - $5.35 $315,962 - $500,117
93,480 Added 620.68%
108,541 $522,000
Q2 2021

Aug 16, 2021

BUY
$4.12 - $5.87 $62,051 - $88,408
15,061 New
15,061 $69,000
Q4 2020

Feb 16, 2021

SELL
$1.05 - $3.67 $18,935 - $66,184
-18,034 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$1.44 - $2.1 $24,696 - $36,015
-17,150 Reduced 48.74%
18,034 $26,000
Q2 2020

Aug 14, 2020

SELL
$1.75 - $2.3 $155 - $204
-89 Reduced 0.25%
35,184 $70,000
Q1 2020

May 15, 2020

BUY
$1.8 - $4.28 $63,491 - $150,968
35,273 New
35,273 $69,000
Q4 2017

Feb 14, 2018

SELL
$8.77 - $12.28 $126,340 - $176,905
-14,406 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$12.17 - $16.3 $175,321 - $234,817
14,406
14,406 $177,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $145M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.